Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
25%
OVERLAP
BY WEIGHT
18
# OF OVERLAPPING
HOLDINGS
FBT
31
HOLDINGS
60%
ALSO IN WDNA
WDNA
90
HOLDINGS
21%
ALSO IN FBT
SECTOR DRIFT (FBT minus WDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 3.3% | 3.7% | 3.3% |
|
VERACYTE INC | 3.6% | 2.1% | 2.1% |
|
GILEAD SCIENCES INC | 3.3% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 2.7% | 1.8% | 1.8% |
|
UNITED THERAPEUTICS CORP | 3.4% | 1.7% | 1.7% |
FBT Overweight Relative to WDNA
|
HALOZYME THERAPEUTICS INC | 4.0% |
|
BEIGENE LTD. SPONSORED ADR | 4.0% |
|
INCYTE CORP | 4.0% |
|
ACADIA PHARMACEUTICALS INC | 3.9% |
 |
METTLER-TOLEDO INTERNATIONAL | 3.4% |
|
KRYSTAL BIOTECH, INC. | 3.2% |
|
NEUROCRINE BIOSCIENCES INC | 3.2% |
 |
ALKERMES PLC | 3.1% |
|
CORCEPT THERAPEUTICS INC | 3.1% |
|
ALNYLAM PHARMACEUTICALS INC | 3.0% |
FBT Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -3.3% |
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
ELI LILLY & CO | -2.7% |
|
BLUEPRINT MEDICINES CORP. | -2.6% |
|
VERICEL CORPORATION | -2.6% |
|
BRIDGEBIO PHARMA, INC. | -2.4% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
|
NOVARTIS AG | -1.7% |
|
BRISTOL-MYERS SQUIBB CO | -1.5% |
|
LABCORP HOLDINGS | -1.5% |